Literature DB >> 14694199

Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cells.

Shahab Uddin1, Jeong Ah-Kang, Jodie Ulaszek, Dolores Mahmud, Amittha Wickrema.   

Abstract

p38alpha, p38beta, p38gamma, and p38delta are four isoforms of p38 mitogen-activated protein (MAP) kinase (MAPK) involved in multiple cellular functions such as cell proliferation, differentiation, apoptosis, and inflammation response. In the present study, we examined the mRNA expression pattern of each of the four isoforms during erythroid differentiation of primary erythroid progenitors. We show that p38alpha and p38gamma transcripts are expressed in early hematopoietic progenitors as well as in late differentiating erythroblasts, whereas p38delta mRNA is only expressed and active during the terminal phase of erythroid differentiation. On the other hand, p38beta is minimally expressed in early CD34(+) hematopoietic progenitors but not expressed in lineage-committed erythroid progenitors. We also determined the phosphorylation/activation of p38alpha, MAPK kinase 3/6, and MAPKAP-2 in response to erythropoietin and stem cell factor. We found that phosphorylation of p38alpha, MAPK kinase kinase 3/6 and MAPKAP-2 occurs only upon growth factor withdrawal in primary erythroid progenitors. Moreover, our data indicate that activation of p38alpha does not induce apoptosis or promote proliferation of erythroid progenitors. On the other hand, under steady-state culture conditions, both p38alpha and p38delta isoforms are increasingly phosphorylated activated in the terminal phase of differentiation. This increased phosphorylation/activity was accompanied by up-regulation of heat shock protein 27 phosphorylation. Finally, we demonstrate that tumor necrosis factor alpha, an inflammatory cytokine that is modulated by p38alpha, is expressed by differentiating erythroblasts and inhibition of p38alpha or tumor necrosis factor alpha results in reduction in differentiation. Taken together, our data demonstrate that both p38alpha and delta isoforms function to promote the late-stage differentiation of primary erythroid progenitors and are likely to be involved in functions related to erythrocyte membrane remodeling and enucleation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14694199      PMCID: PMC314153          DOI: 10.1073/pnas.0307075101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Purification and activation of recombinant p38 isoforms alpha, beta, gamma, and delta.

Authors:  G A Keesler; J Bray; J Hunt; D A Johnson; T Gleason; Z Yao; S W Wang; C Parker; H Yamane; C Cole; H S Lichenstein
Journal:  Protein Expr Purif       Date:  1998-11       Impact factor: 1.650

2.  Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis.

Authors:  A Cuenda; P Cohen
Journal:  J Biol Chem       Date:  1999-02-12       Impact factor: 5.157

3.  Cooperation of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways during granulocyte colony-stimulating factor-induced hemopoietic cell proliferation.

Authors:  O Rausch; C J Marshall
Journal:  J Biol Chem       Date:  1999-02-12       Impact factor: 5.157

4.  p38 mitogen-activated protein kinase activation is required for fibroblast growth factor-2-stimulated cell proliferation but not differentiation.

Authors:  P Maher
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

5.  Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation.

Authors:  Y Nagata; N Takahashi; R J Davis; K Todokoro
Journal:  Blood       Date:  1998-09-15       Impact factor: 22.113

6.  Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6.

Authors:  H Enslen; J Raingeaud; R J Davis
Journal:  J Biol Chem       Date:  1998-01-16       Impact factor: 5.157

7.  Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis.

Authors:  Y Nagata; K Todokoro
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

8.  Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages.

Authors:  K K Hale; D Trollinger; M Rihanek; C L Manthey
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

9.  A Mycoplasma fermentans-derived synthetic lipopeptide induces AP-1 and NF-kappaB activity and cytokine secretion in macrophages via the activation of mitogen-activated protein kinase pathways.

Authors:  J Garcia; B Lemercier; S Roman-Roman; G Rawadi
Journal:  J Biol Chem       Date:  1998-12-18       Impact factor: 5.157

10.  Differential activation of stress-activated protein kinase kinases SKK4/MKK7 and SKK1/MKK4 by the mixed-lineage kinase-2 and mitogen-activated protein kinase kinase (MKK) kinase-1.

Authors:  A Cuenda; D S Dorow
Journal:  Biochem J       Date:  1998-07-01       Impact factor: 3.857

View more
  54 in total

1.  The proinflammatory cytokine GM-CSF downregulates fetal hemoglobin expression by attenuating the cAMP-dependent pathway in sickle cell disease.

Authors:  Tohru Ikuta; Adekunle D Adekile; Diana R Gutsaeva; James B Parkerson; Shobha D Yerigenahally; Betsy Clair; Abdullah Kutlar; Nadine Odo; C Alvin Head
Journal:  Blood Cells Mol Dis       Date:  2011-09-25       Impact factor: 3.039

Review 2.  Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease.

Authors:  Betty S Pace; Li Liu; Biaoru Li; Levi H Makala
Journal:  Exp Biol Med (Maywood)       Date:  2015-08

3.  Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors.

Authors:  Tony A Navas; Mani Mohindru; Myka Estes; Jing Ying Ma; Lubomir Sokol; Perry Pahanish; Simrit Parmar; Edwin Haghnazari; Li Zhou; Robert Collins; Irene Kerr; Aaron N Nguyen; Yin Xu; Leonidas C Platanias; Alan A List; Linda S Higgins; Amit Verma
Journal:  Blood       Date:  2006-08-29       Impact factor: 22.113

4.  Differential requirements for survivin in hematopoietic cell development.

Authors:  Sandeep Gurbuxani; Yanfei Xu; Ganesan Keerthivasan; Amittha Wickrema; John D Crispino
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-29       Impact factor: 11.205

5.  p38 MAP kinase regulation of oligodendrocyte differentiation with CREB as a potential target.

Authors:  Narayan R Bhat; Peisheng Zhang; Sangeeta B Mohanty
Journal:  Neurochem Res       Date:  2007-01-19       Impact factor: 3.996

6.  Friend of GATA-1-independent transcriptional repression: a novel mode of GATA-1 function.

Authors:  Kirby D Johnson; Meghan E Boyer; Jeong-Ah Kang; Amittha Wickrema; Alan B Cantor; Emery H Bresnick
Journal:  Blood       Date:  2007-03-05       Impact factor: 22.113

7.  Alternative pre-mRNA splicing switches modulate gene expression in late erythropoiesis.

Authors:  Miki L Yamamoto; Tyson A Clark; Sherry L Gee; Jeong-Ah Kang; Anthony C Schweitzer; Amittha Wickrema; John G Conboy
Journal:  Blood       Date:  2009-02-04       Impact factor: 22.113

8.  JNK-mediated turnover and stabilization of the transcription factor p45/NF-E2 during differentiation of murine erythroleukemia cells.

Authors:  Tung-Liang Lee; Yu-Chiau Shyu; Pang-Hung Hsu; Chiung-Wen Chang; Shau-Ching Wen; Wei-Yuan Hsiao; Ming-Daw Tsai; Che-Kun James Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

9.  Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes.

Authors:  Sriram Sundaravel; Ryan Duggan; Tushar Bhagat; David L Ebenezer; Hui Liu; Yiting Yu; Matthias Bartenstein; Madhu Unnikrishnan; Subhradip Karmakar; Ting-Chun Liu; Ingrid Torregroza; Thomas Quenon; John Anastasi; Kathy L McGraw; Andrea Pellagatti; Jacqueline Boultwood; Vijay Yajnik; Andrew Artz; Michelle M Le Beau; Ulrich Steidl; Alan F List; Todd Evans; Amit Verma; Amittha Wickrema
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

10.  Activation of protein kinase C{eta} by type I interferons.

Authors:  Amanda J Redig; Antonella Sassano; Beata Majchrzak-Kita; Efstratios Katsoulidis; Hui Liu; Jessica K Altman; Eleanor N Fish; Amittha Wickrema; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.